drugset / Trial / NCT06677996
A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants
NaSingle-groupOpen-labelOther
Summary
This is an open label, fixed sequence, 1-way crossover drug-drug interaction (DDI) study in healthy participants.
Timeline
- Start
- 2024-11-11
- Primary completion
- 2024-12-30
- Completion
- 2025-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 200 mg | — |
| Subject | varegacestat | Small molecule | — | — |
Indications
No indication recorded.